Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
Conditions : Sickle Cell Disease; Sickle Cell Anemia in Children Interventions : Drug: hydroxycarbamide Sponsors : Children's Hospital Medical Center, Cincinnati; Makerere University; Indiana…
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.